论文部分内容阅读
目前,肺癌是世界上发病率最高的恶性肿瘤。在肺癌中晚期空洞性肺癌因病变范围大,患者症状严重,并发症多,形态不规则,并且是许多微创介入治疗的禁忌证,处理很困难,没有较好临床经验可循,往往许多患者放弃治疗。笔者采用CT导引下在组织间植入Ⅰ~(125)粒子治疗了18例晚期空洞性肺癌患者,取得了满意疗效。一、材料和方法1．临床资料2004年11月-2005年7月,我们共治疗晚期空洞性肺癌患者18例,男12例、女6例,年龄44-75岁,平均59．5岁。术前做CT增强扫描,肿瘤均属于周围型肺癌。按病理分类:腺癌2例,小细胞肺癌1例,鳞癌15例。
At present, lung cancer is the most malignant tumor in the world. In the late stage of lung cancer due to a large range of lung cancer, patients with severe symptoms, multiple complications, irregular shape, and many minimally invasive interventional treatment contraindications, the treatment is difficult, there is no good clinical experience to follow, often in many patients Abandon treatment. I use CT-guided implantation of I ~ (125) particles in the tissue of 18 patients with advanced lung cancer, and achieved satisfactory results. First, materials and methods 1. Clinical data November 2004 - July 2005, we treated a total of 18 cases of advanced lung cancer in patients with empty, 12 males and 6 females, aged 44-75 years, mean 59.5 years old. Preoperative CT enhanced scan, the tumor belongs to the surrounding lung cancer. According to the pathological classification: adenocarcinoma in 2 cases, small cell lung cancer in 1 case, squamous cell carcinoma in 15 cases.